Purpose of the Test
- Early detection of prostate cancer probability.
- Distinguishing between benign hyperplasia and malignancy.
- Reducing the need for unnecessary prostate biopsies.
An advanced laboratory test combining three prostate measurements to provide a precise risk score for cancer detection, helping in clinical decision-making and potentially avoiding unnecessary biopsies.
Scientific name: Prostate Health Index (PHI) Test
An advanced blood test measuring Total PSA, Free PSA, and p2PSA to estimate prostate cancer probability in men with borderline PSA levels, reducing the need for invasive biopsies.